RONALD A. WILLIAMS - 05 Jan 2024 Form 4 Insider Report for agilon health, inc. (AGL)

Role
Director
Signature
/s/ Steve Meetre, as Attorney-in-Fact
Issuer symbol
AGL
Transactions as of
05 Jan 2024
Net transactions value
+$1,400,000
Form type
4
Filing time
09 Jan 2024, 16:54:16 UTC
Previous filing
04 Jan 2024
Next filing
03 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGL Common Stock Options Exercise $950,000 +950,000 +39% $1.00* 3,414,414 05 Jan 2024 Direct
transaction AGL Common Stock Options Exercise $450,000 +150,000 +4.4% $3.00* 3,564,414 05 Jan 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGL Options (Rights to Buy) Options Exercise $0 -950,000 -100% $0.000000* 0 05 Jan 2024 Common Stock 950,000 $1.00 Direct F1
transaction AGL Options (Rights to Buy) Options Exercise $0 -150,000 -100% $0.000000* 0 05 Jan 2024 Common Stock 150,000 $3.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options were granted on December 30, 2016, and fully vested on July 1, 2020.
F2 These options were granted on April 27, 2017, and fully vested on September 14, 2021.